# The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis

> **NCT04684823** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 12 (actual)

## Conditions studied

- Cystic Fibrosis
- Adherence, Medication

## Interventions

- **DEVICE:** Patch Cap
- **DEVICE:** Patch App

## Key facts

- **NCT ID:** NCT04684823
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-15
- **Primary completion:** 2021-12-27
- **Final completion:** 2021-12-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684823, "The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04684823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*